145 related articles for article (PubMed ID: 38353233)
1. Role of the NO-GC/cGMP signaling pathway in platelet biomechanics.
Balmes A; Rodríguez JG; Seifert J; Pinto-Quintero D; Khawaja AA; Boffito M; Frye M; Friebe A; Emerson M; Seta F; Feil R; Feil S; Schäffer TE
Platelets; 2024 Dec; 35(1):2313359. PubMed ID: 38353233
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide-sensitive guanylyl cyclase is the only nitric oxide receptor mediating platelet inhibition.
Dangel O; Mergia E; Karlisch K; Groneberg D; Koesling D; Friebe A
J Thromb Haemost; 2010 Jun; 8(6):1343-52. PubMed ID: 20149081
[TBL] [Abstract][Full Text] [Related]
3. The NO/cGMP/PKG pathway in platelets: The therapeutic potential of PDE5 inhibitors in platelet disorders.
Degjoni A; Campolo F; Stefanini L; Venneri MA
J Thromb Haemost; 2022 Nov; 20(11):2465-2474. PubMed ID: 35950928
[TBL] [Abstract][Full Text] [Related]
4. A shear-dependent NO-cGMP-cGKI cascade in platelets acts as an auto-regulatory brake of thrombosis.
Wen L; Feil S; Wolters M; Thunemann M; Regler F; Schmidt K; Friebe A; Olbrich M; Langer H; Gawaz M; de Wit C; Feil R
Nat Commun; 2018 Oct; 9(1):4301. PubMed ID: 30327468
[TBL] [Abstract][Full Text] [Related]
5. Activation of haem-oxidized soluble guanylyl cyclase with BAY 60-2770 in human platelets lead to overstimulation of the cyclic GMP signaling pathway.
Mendes-Silverio CB; Leiria LO; Morganti RP; Anhê GF; Marcondes S; Mónica FZ; De Nucci G; Antunes E
PLoS One; 2012; 7(11):e47223. PubMed ID: 23144808
[TBL] [Abstract][Full Text] [Related]
6. cGMP signaling inhibits platelet shape change through regulation of the RhoA-Rho Kinase-MLC phosphatase signaling pathway.
Aburima A; Walladbegi K; Wake JD; Naseem KM
J Thromb Haemost; 2017 Aug; 15(8):1668-1678. PubMed ID: 28509344
[TBL] [Abstract][Full Text] [Related]
7. Effects of the NO/soluble guanylate cyclase/cGMP system on the functions of human platelets.
Makhoul S; Walter E; Pagel O; Walter U; Sickmann A; Gambaryan S; Smolenski A; Zahedi RP; Jurk K
Nitric Oxide; 2018 Jun; 76():71-80. PubMed ID: 29550521
[TBL] [Abstract][Full Text] [Related]
8. The sGC stimulator riociguat inhibits platelet function in washed platelets but not in whole blood.
Reiss C; Mindukshev I; Bischoff V; Subramanian H; Kehrer L; Friebe A; Stasch JP; Gambaryan S; Walter U
Br J Pharmacol; 2015 Nov; 172(21):5199-210. PubMed ID: 26282717
[TBL] [Abstract][Full Text] [Related]
9. Lack of effect of ODQ does not exclude cGMP signalling via NO-sensitive guanylyl cyclase.
Lies B; Groneberg D; Gambaryan S; Friebe A
Br J Pharmacol; 2013 Sep; 170(2):317-27. PubMed ID: 23763290
[TBL] [Abstract][Full Text] [Related]
10. Differentiation of cGMP-dependent and -independent nitric oxide effects on platelet apoptosis and reactive oxygen species production using platelets lacking soluble guanylyl cyclase.
Rukoyatkina N; Walter U; Friebe A; Gambaryan S
Thromb Haemost; 2011 Nov; 106(5):922-33. PubMed ID: 21800013
[TBL] [Abstract][Full Text] [Related]
11. Soluble guanylyl cyclase activation with HMR1766 attenuates platelet activation in diabetic rats.
Schäfer A; Flierl U; Kobsar A; Eigenthaler M; Ertl G; Bauersachs J
Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2813-8. PubMed ID: 17023677
[TBL] [Abstract][Full Text] [Related]
12. The soluble guanylate cyclase stimulator riociguat and the soluble guanylate cyclase activator cinaciguat exert no direct effects on contractility and relaxation of cardiac myocytes from normal rats.
Reinke Y; Gross S; Eckerle LG; Hertrich I; Busch M; Busch R; Riad A; Rauch BH; Stasch JP; Dörr M; Felix SB
Eur J Pharmacol; 2015 Nov; 767():1-9. PubMed ID: 26407652
[TBL] [Abstract][Full Text] [Related]
13. Aged Garlic Extract Inhibits Human Platelet Aggregation by Altering Intracellular Signaling and Platelet Shape Change.
Rahman K; Lowe GM; Smith S
J Nutr; 2016 Feb; 146(2):410S-415S. PubMed ID: 26764324
[TBL] [Abstract][Full Text] [Related]
14. A phosphoinositide 3-kinase-AKT-nitric oxide-cGMP signaling pathway in stimulating platelet secretion and aggregation.
Stojanovic A; Marjanovic JA; Brovkovych VM; Peng X; Hay N; Skidgel RA; Du X
J Biol Chem; 2006 Jun; 281(24):16333-9. PubMed ID: 16613861
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide inhibits platelet adhesion to collagen through cGMP-dependent and independent mechanisms: the potential role for S-nitrosylation.
Irwin C; Roberts W; Naseem KM
Platelets; 2009 Nov; 20(7):478-86. PubMed ID: 19852686
[TBL] [Abstract][Full Text] [Related]
16. Altered nitric oxide/cGMP platelet signaling pathway in platelets from patients with acute coronary syndromes.
Bergandi L; Cordero M; Anselmino M; Ferraro G; Ravera L; Dalmasso P; Moiraghi C; Trevi GP; Ghigo D; Bosia A; Bergerone S
Clin Res Cardiol; 2010 Sep; 99(9):557-64. PubMed ID: 20467748
[TBL] [Abstract][Full Text] [Related]
17. Effects of non-surgical periodontal treatment on the L-arginine-nitric oxide pathway and oxidative status in platelets.
Siqueira MA; Fischer RG; Pereira NR; Martins MA; Moss MB; Mendes-Ribeiro AC; Figueredo CM; Brunini TM
Exp Biol Med (Maywood); 2013 Jun; 238(6):713-22. PubMed ID: 23918883
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the L-arginine-NO-cGMP pathway in spontaneously hypertensive rat platelets: the effects of pregnancy.
Ognibene DT; Moss MB; Matsuura C; Brunini TM; de Moura RS; Mendes-Ribeiro AC; Resende AC
Hypertens Res; 2010 Sep; 33(9):899-904. PubMed ID: 20555333
[TBL] [Abstract][Full Text] [Related]
19. Direct activation of PDE5 by cGMP: long-term effects within NO/cGMP signaling.
Mullershausen F; Friebe A; Feil R; Thompson WJ; Hofmann F; Koesling D
J Cell Biol; 2003 Mar; 160(5):719-27. PubMed ID: 12604588
[TBL] [Abstract][Full Text] [Related]
20. An ex vivo standardized assay to measure human platelet cGMP.
di Villa Bianca Rd; Mitidieri E; Mirone V; Fusco F; Imbimbo C; Cirino G; Sorrentino R
J Pharmacol Toxicol Methods; 2011; 64(2):164-7. PubMed ID: 21801844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
